Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History EDSA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics EDSA

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Edesa Biotech Inc

EDSA
Current price
2.00 USD -0.09 USD (-4.31%)
Last closed 1.96 USD
ISIN CA27966L1085
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 14 291 154 USD
Yield for 12 month -54.29 %
1Y
3Y
5Y
10Y
15Y
EDSA
21.11.2021 - 28.11.2021

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 3 clinical study to treat chronic allergic contact dermatitis. The company develops EB07, a monoclonal antibody, which is in Phase 2 clinical study for the treatment of pulmonary fibrosis; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada. Address: 100 Spy Court, Markham, ON, Canada, L3R 5H6

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13.00 USD

P/E ratio

Dividend Yield

Financials EDSA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures EDSA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-183 471 USD

Current Quarter

Last Quarter

EBITDA -6 387 352 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -35.29 %
PEG Ratio
Return On Equity TTM -58.78 %
Wall Street Target Price 13.00 USD
Revenue TTM 500 USD
Book Value 0.91 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -99.90 %
Dividend Yield
Gross Profit TTM 311 200 USD
Earnings per share -1.55 USD
Diluted Eps TTM -1.55 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation EDSA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 0.17
Enterprise Value Revenue 128 525.38
Price Sales TTM 120 477.93
Enterprise Value EBITDA -1.25
Price Book MRQ 2.25

Technical indicators EDSA

For 52 weeks

1.55 USD 5.59 USD
50 Day MA 2.13 USD
Shares Short Prior Month 22 317
200 Day MA 2.59 USD
Short Ratio 0.43
Shares Short 13 592
Short Percent 0.23 %